Intelligent Bio Solutions (INBS) vs enVVeno Medical (NVNO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
enVVeno Medical is the larger company by market cap ($5.7 million vs $5.2 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INBS | NVNO |
|---|---|---|
| Share price | $1.57 | $8.18 |
| Market cap | $5.21M | $5.68M |
| 1-day change | -1.26% | -2.68% |
| Forward P/E | 4.49 | — |
| EPS (TTM) | $-8.44 | $-25.15 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $24.90 | $30.80 |
| 52-week low | $1.52 | $7.01 |
| Distance from 52-week high | -93.69% | -73.46% |
| Analyst consensus | none | none |
| Avg. price target upside | +664.33% | +266.97% |
| Average volume | 160.86K | 23.71K |
| Shares outstanding | 3.32M | 694.83K |
| Employees | 59 | 33 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Intelligent Bio Solutions
INBS stock →Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform.
Healthcare · Medical Devices · 59 employees
About enVVeno Medical
NVNO stock →enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency.
Healthcare · Medical Devices · 33 employees
INBS vs NVNO FAQ
Which is bigger, Intelligent Bio Solutions or enVVeno Medical?
enVVeno Medical (NVNO) is larger, with a market capitalization of $5.68M compared with $5.21M for Intelligent Bio Solutions (INBS).
Are Intelligent Bio Solutions and enVVeno Medical in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.